NIR-II photozymes with stoichiometric chemistry-regulated enzyocatalytic activities for multi-modal nanocatalytic therapy
Chemical Communications · 2026
DOI: 10.1039/d5cc05646b ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Communications, 2026. Verfasst von Zhengzheng Lin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Materdicine Lab, School of Life Sciences, Shanghai University, Shanghai, 200444, P. R. China. liangchenbio@shu.edu.cn. Hauptthemen laut MEDLINE: Antineoplastic Agents, Photosensitizing Agents. Die Arbeit nennt 22 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shanghai Municipality.
Abstract (Originalsprache)
Nanocatalytic therapy faces limitations from low ROS efficiency and high intracellular GSH. Here a NIR-II-responsive photozyme was developed for multi-modal nanocatalytic therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Materdicine Lab, School of Life Sciences, Shanghai University, Shanghai, 200444, P. R. China. liangchenbio@shu.edu.cn.
- School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai 200240, China. shenyi12@sjtu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shanghai Municipality
Zitieren
APA
Lin, Z., Song, Z., Shen, H., Shen, Y., Chen, L., & Chen, Y. (2026). NIR-II photozymes with stoichiometric chemistry-regulated enzyocatalytic activities for multi-modal nanocatalytic therapy. Chemical Communications. https://doi.org/10.1039/d5cc05646b
Vancouver
Lin Z, Song Z, Shen H, Shen Y, Chen L, Chen Y. NIR-II photozymes with stoichiometric chemistry-regulated enzyocatalytic activities for multi-modal nanocatalytic therapy. Chemical Communications. 2026. doi:10.1039/d5cc05646b
BibTeX
@article{Lin2026,
author = {Lin, Zhengzheng and Song, Ziying and Shen, He and Shen, Yi and Chen, Liang and Chen, Yu},
title = {NIR-II photozymes with stoichiometric chemistry-regulated enzyocatalytic activities for multi-modal nanocatalytic therapy},
journal = {Chemical Communications},
year = {2026},
doi = {10.1039/d5cc05646b}
}
EUVIMED